Rhumbline Advisers Reduces Stake in Castle Biosciences, Inc. (NASDAQ:CSTL)
Rhumbline Advisers reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,892 shares of the company’s stock after selling 1,009 shares during the quarter. Rhumbline Advisers’ holdings in […]
Rhumbline Advisers reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 39,892 shares of the company’s stock after selling 1,009 shares during the quarter. Rhumbline Advisers’ holdings in […]
